Updated
Updated · Bloomberg · May 22CVC, GBL Offer $12 Billion for Recordati as €51.29 Bid Tops March 25 Close by 13%
3 articles · Updated · Bloomberg · May 22
- $12 billion-plus is the value CVC Capital Partners and Groupe Bruxelles Lambert put on Recordati in a voluntary cash tender offer announced Friday.
- €51.29 per share is the all-cash price, giving Recordati investors about a 13% premium to the stock's March 25 close.
- March 25 marked CVC's earlier non-binding approach to Recordati's board, with the new bid turning that interest into a formal takeover attempt.
- The proposed acquisition would rank among Europe's biggest healthcare deals of 2026 if completed.
What hidden value does CVC plan to unlock in Recordati that public markets have failed to see? Is private equity's buyout of Recordati the new blueprint for pharma's survival amid a $400B patent cliff?